IN2014CN04599A - - Google Patents

Info

Publication number
IN2014CN04599A
IN2014CN04599A IN4599CHN2014A IN2014CN04599A IN 2014CN04599 A IN2014CN04599 A IN 2014CN04599A IN 4599CHN2014 A IN4599CHN2014 A IN 4599CHN2014A IN 2014CN04599 A IN2014CN04599 A IN 2014CN04599A
Authority
IN
India
Prior art keywords
culture medium
subjecting
serum
aggregate
signaling pathway
Prior art date
Application number
Other languages
English (en)
Inventor
Tokushige Nakano
Satoshi Ando
Yoshiki Sasai
Mototsugu Eiraku
Original Assignee
Sumitomo Chemical Co
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2012043080A external-priority patent/JP5985207B2/ja
Priority claimed from JP2012043081A external-priority patent/JP5985208B2/ja
Priority claimed from JP2012043082A external-priority patent/JP5985209B2/ja
Priority claimed from JP2012043083A external-priority patent/JP6067232B2/ja
Application filed by Sumitomo Chemical Co, Riken filed Critical Sumitomo Chemical Co
Publication of IN2014CN04599A publication Critical patent/IN2014CN04599A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
IN4599CHN2014 2011-11-25 2012-11-22 IN2014CN04599A (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2011258210 2011-11-25
JP2011258209 2011-11-25
JP2011258211 2011-11-25
JP2011258212 2011-11-25
JP2012043080A JP5985207B2 (ja) 2011-11-25 2012-02-29 網膜色素上皮細胞の製造方法
JP2012043081A JP5985208B2 (ja) 2011-11-25 2012-02-29 網膜組織の製造方法
JP2012043082A JP5985209B2 (ja) 2011-11-25 2012-02-29 眼杯様構造体の製造方法
JP2012043083A JP6067232B2 (ja) 2011-11-25 2012-02-29 網膜層特異的神経細胞を製造する方法
PCT/JP2012/080366 WO2013077425A1 (ja) 2011-11-25 2012-11-22 網膜組織及び網膜関連細胞の製造方法

Publications (1)

Publication Number Publication Date
IN2014CN04599A true IN2014CN04599A (de) 2015-09-18

Family

ID=51221042

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4599CHN2014 IN2014CN04599A (de) 2011-11-25 2012-11-22

Country Status (9)

Country Link
US (2) US10973854B2 (de)
EP (1) EP2784152B1 (de)
KR (1) KR102111936B1 (de)
CN (2) CN113817679A (de)
AU (1) AU2012341417B2 (de)
CA (2) CA2856867C (de)
ES (1) ES2733956T3 (de)
IN (1) IN2014CN04599A (de)
WO (1) WO2013077425A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973854B2 (en) * 2011-11-25 2021-04-13 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
CN104508125B (zh) 2012-06-08 2020-06-16 住友化学株式会社 用于产生睫状边缘带样结构的方法
CA2906815A1 (en) 2013-03-15 2014-09-18 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
CN105683366B (zh) * 2013-08-23 2020-11-06 住友化学株式会社 用于制备视网膜组织和视网膜相关细胞的方法
CA2930092C (en) 2013-11-11 2024-03-12 Sumitomo Chemical Company, Limited Method for producing retinal pigment epithelial cells
BR112016011096A2 (pt) 2013-11-27 2017-09-19 Kyoto Prefectural Public Univ Corp Aplicação de laminina à cultura de célula endotelial da córnea
AU2014362722B2 (en) 2013-12-11 2021-06-10 Riken Method for manufacturing ciliary marginal zone-like structure
SG11201605833PA (en) 2014-01-17 2016-08-30 Sumitomo Chemical Co Method for manufacturing ciliary margin stem cells
US10280400B2 (en) 2014-05-05 2019-05-07 Indiana University Research And Technology Corporation Method for producing retinal ganglion cells from pluripotent cells
JP6039128B2 (ja) * 2014-08-08 2016-12-07 国立研究開発法人国立成育医療研究センター 網膜神経節細胞の作製方法
AU2015336454B2 (en) 2014-10-24 2021-04-29 Racthera Co., Ltd. Production method for retinal tissue
CN113564123B (zh) * 2014-10-24 2024-11-15 住友制药株式会社 神经组织的制备方法
MX387839B (es) 2014-10-31 2025-03-04 Senju Pharma Co Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea.
JP6770435B2 (ja) 2014-10-31 2020-10-14 京都府公立大学法人 ラミニンによる網膜および神経の新規治療
JP6884354B2 (ja) * 2015-09-08 2021-06-09 大日本住友製薬株式会社 網膜組織の製造方法
CN106754636B (zh) * 2015-11-19 2019-08-30 中国人民解放军第二军医大学 体外诱导原代肝细胞胆管化并长期培养、扩增和分化的方法及其应用
JP6995314B2 (ja) * 2016-04-22 2022-02-21 大日本住友製薬株式会社 網膜組織の製造法
WO2018097253A1 (ja) 2016-11-25 2018-05-31 国立研究開発法人理化学研究所 移植用細胞集団及びその製造方法
EP3332695B1 (de) * 2016-12-09 2021-05-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Messgerät
WO2018146679A2 (en) 2017-02-08 2018-08-16 Hadasit Medical Research Services And Development Ltd. Photoreceptor cells for the treatment of retinal diseases
EP3618763A4 (de) * 2017-05-08 2021-02-17 Lambdavision Incorporated Verfahren zur stimulierung von netzhautzellen und zur behandlung von sehverlust
JP7248246B2 (ja) 2017-07-20 2023-03-29 国立研究開発法人理化学研究所 神経組織の保存方法
CN110945119B (zh) * 2017-07-20 2024-04-05 国立研究开发法人理化学研究所 包含连续上皮的视网膜组织的成熟方法
CA3074426A1 (en) 2017-09-08 2019-03-14 Sumitomo Dainippon Pharma Co., Ltd. Cell aggregate including retinal tissue and production method therefor
JP7793137B2 (ja) 2017-09-14 2026-01-05 国立研究開発法人理化学研究所 背側化シグナル伝達物質又は腹側化シグナル伝達物質による錐体視細胞又は桿体視細胞の増加方法
EP3683306A4 (de) 2017-09-14 2021-06-09 Riken Verfahren zur herstellung von retinagewebe
EP3715452A4 (de) * 2017-11-24 2021-08-18 Sumitomo Chemical Company, Limited Herstellungsverfahren einer zellmasse mit neuronalen zellen/gewebe und nicht-neuralem epithelgewebe und zellmasse daraus
US12497591B2 (en) 2018-03-07 2025-12-16 Sorbonne Universite Compositions and methods for efficient amplification of retinal progenitors cells
US20200149003A1 (en) * 2018-04-20 2020-05-14 Miami University Methods for the production of retinal cells
KR102142400B1 (ko) 2018-06-19 2020-08-07 서울대학교산학협력단 돼지 만능성 줄기세포 배양용 배지 조성물
WO2020138430A1 (ja) 2018-12-28 2020-07-02 国立研究開発法人理化学研究所 網膜系細胞又は網膜組織の障害を伴う疾患の治療薬
SG11202109855PA (en) 2019-03-13 2021-10-28 Sumitomo Dainippon Pharma Co Ltd Method for evaluating quality of transplant neural retina, and transplant neural retina sheet
US12534705B2 (en) * 2019-03-29 2026-01-27 Kaneka Corporation Method for producing pluripotent stem cells
WO2020218480A1 (ja) 2019-04-26 2020-10-29 国立研究開発法人理化学研究所 神経網膜と網膜色素上皮細胞とハイドロゲルとを含む複合体及びその製造方法
KR20230019453A (ko) * 2020-05-29 2023-02-08 후지필름 셀룰러 다이내믹스, 인코포레이티드 망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법
JPWO2022054925A1 (de) 2020-09-11 2022-03-17
EP4201428A4 (de) 2020-09-11 2024-09-11 Sumitomo Pharma Co., Ltd. Medium für gewebetransplantation
KR20240103018A (ko) 2021-11-19 2024-07-03 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 시트상 망막 조직의 제조 방법
CA3247979A1 (en) 2022-01-12 2025-02-25 Riken Tissue transplant resin tip, tissue transplant device, retinal tissue transplant procedure, and retinal tissue transplant kit
WO2024143436A1 (ja) 2022-12-28 2024-07-04 株式会社VC Cell Therapy 網膜シートの製造方法
TW202444894A (zh) 2023-03-29 2024-11-16 日商住友製藥股份有限公司 視網膜組織之製造方法
CN116445409B (zh) * 2023-06-16 2023-09-22 中国人民解放军总医院第三医学中心 视杆感光前体细胞的制备方法及其应用
CN122182781B (zh) * 2026-05-14 2026-07-17 中南大学湘雅二医院 一种酪蛋白激酶1δ抑制剂在制备青光眼及高眼压症治疗药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216439A1 (en) * 1996-09-25 1998-03-25 Derek Van Der Kooy Pharmaceuticals containing retinal stem cells
JP2001508302A (ja) 1997-01-10 2001-06-26 ライフ テクノロジーズ，インコーポレイテッド 胚性幹細胞血清置換
EA007339B1 (ru) 2001-07-27 2006-08-25 Кьюэрис, Инк. Медиаторы путей передачи сигналов генами hedgehog, содержащие их композиции и способы применения указанных веществ
CN101007802A (zh) * 2001-07-27 2007-08-01 柯里斯公司 Hedgehog信号转导途径介质、其相关组合物以及应用
JP5141016B2 (ja) 2004-06-18 2013-02-13 独立行政法人理化学研究所 無血清浮遊培養による胚性幹細胞の神経分化誘導法
WO2006068003A1 (ja) 2004-12-24 2006-06-29 Masahiro Izutsu 携帯情報通信装置、携帯情報通信装置用接続ユニット及び携帯情報通信装置用外部入出力ユニット
US7541186B2 (en) * 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
EP2128244A4 (de) * 2007-01-18 2012-05-09 Riken Verfahren zur induktion/differenzierung zu einer photorezeptorzelle
KR100910517B1 (ko) 2007-03-21 2009-07-31 엔에이치엔비즈니스플랫폼 주식회사 브라우저-로그인 맵핑을 통한 타겟 인벤토리 확장 방법 및시스템
CA2684460C (en) 2007-04-18 2017-01-03 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
EP2209888B1 (de) * 2007-10-12 2019-12-04 Astellas Institute for Regenerative Medicine Verbesserte verfahren zur herstellung von rpe-zellen und zusammensetzungen von rpe-zellen
EP3553170B1 (de) 2009-08-24 2024-02-14 Wisconsin Alumni Research Foundation Weitgehend reiner menschlicher retinavorläufer, vorderhirnvorläufer und retinapigment-epithelzellkulturen sowie verfahren zur herstellung davon
EP2486127B1 (de) * 2009-10-06 2018-03-21 SNU R & DB Foundation Zusammensetzungen zur herbeiführung der differenzierung von retinalzellen aus retinalvorläuferzellen oder zur herbeiführung der proliferation von retinalzellen mit wnt-signalisierungspfad-aktivatoren
EP2486126B1 (de) * 2009-10-06 2017-12-06 SNU R & DB Foundation Verfahren zur differenzierung von retinalzellen aus stammzellen
US10793830B2 (en) * 2009-11-05 2020-10-06 Riken Method for producing retinal tissue in vitro
JP5403374B2 (ja) 2010-08-17 2014-01-29 カシオ計算機株式会社 電子機器
JP2012043081A (ja) 2010-08-17 2012-03-01 Seiko Epson Corp 電子機器、及び、情報管理システム
JP5505192B2 (ja) 2010-08-17 2014-05-28 富士通株式会社 競合試験装置
JP5094932B2 (ja) 2010-08-17 2012-12-12 ヤフー株式会社 情報表示装置、方法及びプログラム
JP5377580B2 (ja) 2011-06-23 2013-12-25 株式会社 テクスピアー 手の甲の認証端末及び手の甲の認証方法
JP2011258211A (ja) 2011-07-05 2011-12-22 Fujitsu Component Ltd 音出力装置
US10973854B2 (en) 2011-11-25 2021-04-13 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
CN105683366B (zh) 2013-08-23 2020-11-06 住友化学株式会社 用于制备视网膜组织和视网膜相关细胞的方法
CA2930092C (en) * 2013-11-11 2024-03-12 Sumitomo Chemical Company, Limited Method for producing retinal pigment epithelial cells
JP6039128B2 (ja) * 2014-08-08 2016-12-07 国立研究開発法人国立成育医療研究センター 網膜神経節細胞の作製方法
AU2015336454B2 (en) * 2014-10-24 2021-04-29 Racthera Co., Ltd. Production method for retinal tissue
JP6995314B2 (ja) * 2016-04-22 2022-02-21 大日本住友製薬株式会社 網膜組織の製造法

Also Published As

Publication number Publication date
CN103998599A (zh) 2014-08-20
US12582677B2 (en) 2026-03-24
AU2012341417A1 (en) 2014-06-26
KR20140097442A (ko) 2014-08-06
CA3114895A1 (en) 2013-05-30
CA2856867A1 (en) 2013-05-30
EP2784152B1 (de) 2019-04-10
CA2856867C (en) 2021-06-01
US20140341864A1 (en) 2014-11-20
CN113817679A (zh) 2021-12-21
WO2013077425A1 (ja) 2013-05-30
EP2784152A4 (de) 2015-11-11
AU2012341417B2 (en) 2018-06-28
US20210228645A1 (en) 2021-07-29
US10973854B2 (en) 2021-04-13
ES2733956T3 (es) 2019-12-03
KR102111936B1 (ko) 2020-05-18
EP2784152A1 (de) 2014-10-01

Similar Documents

Publication Publication Date Title
CA2856867C (en) Methods for producing retinal tissue and retina-related cell
AU2017254264A1 (en) Method for producing retinal tissue
EA201390801A1 (ru) Способ культивирования для получения и поддержания чистой или обогащенной популяции нервных стволовых клеток и/или нервных клеток-предшественников млекопитающего, склонных к дифференцировке с образованием клеток олигодендроцитарной линии in vitro
WO2015054526A3 (en) Methods of mammalian retinal stem cell production and applications
WO2009028631A1 (ja) 角膜内皮細胞接着促進剤
RU2011121843A (ru) Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток
WO2010096588A3 (en) Cell culture media containing combinations of proteins
BR112022017216A2 (pt) Método para produzir células exterminadoras naturais a partir de células-tronco pluripotentes
ES2523998T3 (es) Método de aislamiento de citoblastos dérmicos
PH12014500391A1 (en) Microorganisms and methods for producing 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol and related alcohols
EP4578941A3 (de) Kombinierte chemische und genetische ansätze zur erzeugung induzierter pluripotenter stammzellen
WO2009023525A3 (en) Methods of modulating mesenchymal stem cell differentiation
MX356756B (es) Células madre pluripotentes en microportadores.
EP1789534A4 (de) Isolierung von stamm-/progenitorzellen aus der amnionmembran der nabelschnur
CA2909230C (en) Method for inducing alveolar epithelial progenitor cells
WO2012126013A3 (en) Method for making pluripotent stem cells
MY181513A (en) Cell culture compositions and methods for polypeptide production
MY160164A (en) Isolating method for umbilical cord blood-derived pluripotent stem cells expressing znf281
MX348269B (es) Metodo para producir lamina celular epitelial de pigmento retinal.
IN2014CN03196A (de)
MY184796A (en) Method for manufacturing ciliary marginal zone-like structure
CO2019001232A2 (es) Preparacion farmaceutica antienvejecimiento
WO2010020876A3 (en) Cell culture method to form aggregates
WO2012092542A3 (en) Responsive cell culture hydrogel
WO2009117098A3 (en) Methods for stem cell production and therapy